Mounjaro (Tirzepatide) weight loss injection

Medication features
 

Tirzepatide, sold as Mounjaro in the UK, is a once-weekly injection for type 2 diabetes and weight loss. Start with lower dose 2.5 mg weekly for four weeks, with possible adjustments up to 15 mg. It works by activating GLP-1 to control blood sugar and appetite, and GIP to boost insulin and manage appetite. Unlike Ozempic (semaglutide), which only affects GLP-1, Tirzepatide’s dual action may be more effective for diabetes and weight loss.